Parvimonas

—-

title: Parvimonas type: entity subtype: microbe created: 2026-04-10 updated: 2026-04-16 last_substantive_update: 2026-04-16 sources: [qin-2024-consistent-microbiome-signatures-old-young-onset-crc, saito-2019-metagenomic-gut-microbiota-colorectal-adenoma, wu-2021-microbial-markers-populations-early-crc, zhao-2021-colorectal-cancer-microbiome-patterns-signatures, liu-2021-args-colorectal-cancer-microbiome, hou-2022-gut-microbiota-immune-immunotherapy-crc, bars-cortina-2024-16s-vs-shotgun-crc, osman-2018-16s-rrna-crc-protocols-workflows, catala-valentin-2021-bacterial-host-homeostasis-upper-gi-carcinogenesis] source_count: 9 metal_dependencies: [iron, zinc] key_enzymes: [zinc metalloprotease, iron-dependent oxidoreductases, hemolysin-type toxins] tags: [pathobiont, oral-origin, CRC-enriched, anaerobe, microbial-biomarker, oral-gut-translocation, head-neck-cancer, smoking-enriched] platform: wikibiome seo_target: "Parvimonas micra CRC oral-gut translocation microbial biomarker" wikipedia_differentiation: "Cross-cohort CRC biomarker validation data, iron and zinc dependency for virulence enzyme activity, oral-gut translocation mechanism, association with upper GI carcinogenesis in smokers, and immune microenvironment modulation in CRC beyond Wikipedia's clinical infection focus" conditions_enriched_in: [colorectal-cancer, head-and-neck-squamous-cell-carcinoma, esophageal-cancer] conditions_depleted_in: [] pathogenic_potential: commensal-turned-pathogen gram_stain: "positive" oxygen_requirement: "obligate anaerobe"—-

Parvimonas micra is a Gram-positive, obligate anaerobic coccus of oral origin that has emerged as one of the most consistently enriched microbial biomarkers in colorectal cancer. Its translocation from the oral cavity to the gut tumor microenvironment positions it alongside fusobacterium nucleatum as a key member of the CRC-associated oral microbiome signature, with enrichment also documented in upper GI and oropharyngeal cancers.

Taxonomy and Ecology

• Single species genus: Parvimonas micra (formerly Peptostreptococcus micros or Micromonas micros)
• Member of Peptostreptococcaceae, Clostridiales
• Natural habitat: subgingival plaque, periodontal pockets, and tonsillar crypts — sites of chronic low-grade inflammation
• In healthy individuals, P. micra is a minority member of the oral anaerobe community, held in check by the oral microbiome's balance of Streptococcus, Veillonella, and Neisseria species
• Oral-to-gut translocation requires both a disrupted gut barrier (inflammatory or tumor context) and the ability to survive transit through stomach acid

Metal Dependencies and Virulence Biochemistry

P. micra relies on metal-dependent enzymatic systems for the virulence activities that enable its persistence in tumor microenvironments:

Iron dependency:

• Iron is required for iron-dependent oxidoreductases involved in anaerobic respiration and energy generation in hypoxic tumor niches
• The tumor microenvironment, with its elevated iron from hemorrhage and neovascularization, provides the selective growth advantage for iron-requiring anaerobes
• Iron acquisition may also involve hemolysin-type toxins that lyse erythrocytes for heme-iron scavenging — a capacity documented in the genus

Zinc dependency:

• Zinc-dependent metalloprotease activity supports tissue invasion and degradation of extracellular matrix components
• Zinc metalloproteases are a common virulence mechanism in oral anaerobes; their activity disrupts the collagen-rich extracellular matrix of the gut mucosa, facilitating deeper colonization
• Zinc also supports the neutralization of host reactive oxygen species through zinc-containing superoxide dismutase variants

These metal dependencies are consistent with the general principle that tumor microenvironments — which are iron-replete and zinc-disrupted — selectively favor metal-requiring opportunistic anaerobes over metal-sensitive commensals.

CRC-Associated Enrichment

P. micra appears across virtually every major CRC microbiome study as a robust, cross-cohort biomarker:

• Significantly enriched in both old-onset and young-onset CRC, demonstrating that its association is age-independent — an important validation because confounders affecting the elderly cannot explain enrichment in young-onset CRC ^[1].
• Present in intramucosal CRC tissue alongside Peptostreptococcus, Actinomyces, and Fusobacterium, suggesting involvement from early carcinogenesis stages prior to deep invasion ^[2].
• Identified as a population-wide early CRC marker across geographically diverse cohorts spanning Asian and Western populations ^[3].
• Part of the core CRC microbiome signature that is reproducible across both 16S rRNA amplicon sequencing and shotgun metagenomic approaches — a methodological robustness that elevates its biomarker credibility ^[4].
• Enriched alongside antibiotic resistance genes in the CRC microbiome, raising questions about co-selection in the inflammatory tumor microenvironment ^[5].

Oral-Gut Translocation

• P. micra is a normal inhabitant of the oral cavity, particularly subgingival plaque and periodontal pockets.
• Its consistent enrichment in CRC tissue supports the oral-gut translocation hypothesis: oral pathobionts exploit disrupted gut barriers or tumor-associated hypoxic niches to colonize the colon.
• This translocation pattern is shared with fusobacterium nucleatum, Peptostreptococcus stomatis, and actinomyces, forming a recognizable oral-origin CRC consortium — none of which would be expected in the colon under normal barrier function.
• The association between periodontitis (elevated oral P. micra) and CRC risk provides epidemiological support for translocation as the causal mechanism.
• Oral health as a modifiable risk factor for CRC now has a plausible microbiological mechanism in this translocation pathway.

Upper GI and Head/Neck Cancer

Beyond CRC, Parvimonas enrichment has been documented in upper gastrointestinal and oropharyngeal carcinogenesis ^[6]:

• Smokers: Increased Parvimonas abundance is one of the characteristic microbiome shifts associated with tobacco smoking, alongside Fusobacterium, Bacteroides, and Porphyromonas enrichment.
• Head and neck squamous cell carcinoma (HNSCC): Given its oral habitat and enrichment in smokers (a major HNSCC risk factor), P. micra is implicated in the oral-origin carcinogenesis signature for HNSCC.
• Esophageal cancer: The oral dysbiosis associated with chronic periodontal disease — which elevates P. micra — is a recognized risk factor for esophageal squamous cell carcinoma.

This breadth of upper GI associations is consistent with an organism that is naturally oral, thrives in chronic inflammatory states, and translocates to cancer-associated environments across the GI tract.

Immunotherapy and Immune Context

• The presence of P. micra and other CRC-enriched taxa influences the tumor immune microenvironment and may modulate response to immunotherapy ^[7].
• As a Gram-positive anaerobe, P. micra modulates local immune responses through peptidoglycan-mediated pathways — specifically NOD receptor activation — distinct from the LPS-driven TLR4 signaling of Gram-negative taxa like F. nucleatum. This may create additive or synergistic immune dysregulation when both organisms co-colonize CRC tumors.
• The co-enrichment of P. micra with antibiotic resistance genes in CRC tissue may reflect selection for bacteria capable of surviving the antibiotic pressures of clinical oncology settings.

Diagnostic Biomarker Potential

• P. micra is among the most reliable fecal biomarkers for non-invasive CRC screening, detectable in stool before colonoscopy.
• Stool detection combined with F. nucleatum and Clostridium symbiosum achieves high diagnostic accuracy across CRC stages.
• Microbiome-based classification models incorporating P. micra achieve AUROC values of 0.75–0.90 across validation cohorts ^[1].
• Cross-platform reproducibility (16S and shotgun) increases clinical implementation feasibility ^[4].

Ecological Role in Dysbiosis

In the tumor microenvironment, P. micra likely:

1. Occupies the hypoxic niche: As an obligate anaerobe, it preferentially colonizes the poorly oxygenated tumor core where commensals cannot survive
2. Contributes to chronic inflammation: Peptidoglycan-driven NOD signaling recruits myeloid cells and sustains NF-κB activation
3. Depletes anti-tumor immune activity: Chronic bacterial presence in the tumor promotes an immunosuppressive microenvironment
4. Forms polymicrobial consortia: Its co-occurrence with F. nucleatum, Peptostreptococcus stomatis, and Actinomyces suggests organized biofilm-like communities in tumor tissue

Key Sources

• ^[8]
• ^[9]

Cross-References

• colorectal cancer — most consistently enriched CRC biomarker across populations
• fusobacterium nucleatum — co-enriched oral-origin CRC pathobiont; Gram-negative partner in polymicrobial tumor colonization
• actinomyces — co-occurs in CRC tissue as part of oral translocation consortium
• hungatella — co-enriched alongside P. micra in CRC signatures
• iron — required for virulence enzyme activity in hypoxic tumor microenvironment
• zinc — cofactor for metalloprotease tissue invasion activity
• dysbiosis — oral-gut translocation reflects barrier dysfunction
• biofilm — polymicrobial consortia behavior in tumor tissue
• antimicrobial resistance — co-occurrence with ARGs in CRC microbiome